Single Ascending Dose Study of TD-1439 in Healthy Subjects

Clinical trial NCT02903095 · COMPLETED

Trial details

NCT number: NCT02903095
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2016-09-01
Primary completion: 2016-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.